Karyopharm Therapeutics Inc. buy Royal Bank of Canada
Start price
03.08.23
/
50%
€1.67
Target price
03.08.24
€3.65
Performance (%)
-54.66%
End price
04.08.24
€0.76
Summary
This prediction ended on 04.08.24 with a price of €0.76. The BUY prediction by Royal_Bank_of_Canada for Karyopharm Therapeutics Inc. performed very badly with a performance of -54.66%. Royal_Bank_of_Canada has a follow-up prediction for Karyopharm Therapeutics Inc. where he still thinks Karyopharm Therapeutics Inc. is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Karyopharm Therapeutics Inc. | 27.829% | 27.829% | -33.444% |
| iShares Core DAX® | -1.471% | 1.895% | 25.178% |
| iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% |
| iShares Nikkei 225® | -2.115% | 2.450% | 20.561% |
| iShares S&P 500 | 0.394% | 3.118% | 29.456% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Karyopharm Therapeutics Inc. diskutieren
Karyopharm Therapeutics Inc. (NASDAQ: KPTI) had its price target lowered by analysts at Royal Bank of Canada from $5.00 to $4.00. They now have an "outperform" rating on the stock.
Ratings data for KPTI provided by MarketBeat
In the thread Trading Karyopharm Therapeutics Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten
Current prediction by Royal_Bank_of_Canada for Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.84
03.11.23
03.11.23
€2.80
03.11.24
03.11.24
-4.27%
02.10.24
02.10.24
Stopped prediction by Royal_Bank_of_Canada for Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.72
07.08.24
07.08.24
€2.75
07.08.25
07.08.25
11.02%
02.10.24
02.10.24